Evidence map›Paper›PMID 33177621›Full record

ArticleScientific reports2020

Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.

Sabina Luszczak, Benjamin S Simpson, Urszula Stopka-Farooqui, Vignesh Krishna Sathyadevan, Lina M Carmona Echeverria, Christopher Kumar, Helena Costa, Aiman Haider, Alex Freeman, Charles Jameson and 9 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 2 countries.

Sabina LuszczakMolecular Diagnostics and Therapeutics Group, University College London, London, UK.
Benjamin S SimpsonMolecular Diagnostics and Therapeutics Group, University College London, London, UK.
Urszula Stopka-FarooquiMolecular Diagnostics and Therapeutics Group, University College London, London, UK.
Vignesh Krishna SathyadevanMolecular Diagnostics and Therapeutics Group, University College London, London, UK.
Lina M Carmona EcheverriaMolecular Diagnostics and Therapeutics Group, University College London, London, UK.
Christopher KumarMolecular Diagnostics and Therapeutics Group, University College London, London, UK.
Helena Costa2Research Department of Pathology, University College London, London, UK.
Aiman Haider2Research Department of Pathology, University College London, London, UK.
Alex Freeman2Research Department of Pathology, University College London, London, UK.
Charles Jameson2Research Department of Pathology, University College London, London, UK.
Marzena Ratynska2Research Department of Pathology, University College London, London, UK.
Imen Ben-Salha2Research Department of Pathology, University College London, London, UK.
Ashwin SridharDepartment of Uro‑Oncology, UCLH NHS Foundation Trust, London, UK.
Greg ShawDepartment of Uro‑Oncology, UCLH NHS Foundation Trust, London, UK.
John D KellyDepartment of Uro‑Oncology, UCLH NHS Foundation Trust, London, UK.
Hayley PyeMolecular Diagnostics and Therapeutics Group, University College London, London, UK.
Kathy A GatelyTrinity Translational Medicine Institute, St. James's Hospital Dublin, Dublin 8, Ireland.
Hayley C WhitakerMolecular Diagnostics and Therapeutics Group, University College London, London, UK.
Susan HeaveyMolecular Diagnostics and Therapeutics Group, University College London, London, UK. s.heavey@ucl.ac.uk.
University College London · GBUniversity College Hospital · GBSt. James's Hospital · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID33177621
PMCPMC7658353
OpenAlexW3104225693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.